Clinical Trial Update: A Study to Assess Collagenase Clostridium Histolyticum (CCH) in the Treatment of Plantar Fasciitis (PFA) [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating collagenase clostridium histolyticum for plantar fasciitis has completed. Endo Pharmaceuticals sponsored the study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plantar Fasciitis

Drugs mentioned

• XIAFLEX (Collagenase Clostridium histolyticum)

Snippet

Sponsor: Endo Pharmaceuticals | Conditions: Plantar Fasciitis | Phase 2 | Status: COMPLETED